Variable | 5-year SR | 95% CI | p-value (comparison) | |
---|---|---|---|---|
Metastasis | ||||
yes (TM+) | 73% | 68-77% | < 0.0001 | |
no (TM-) | 21% | 13-31% | ||
Grading | ||||
1 | 73% | 37-90% | 0,6578 (1 vs 2) | |
2 | 67% | 61-72% | 0.1449 (1 vs 3) | |
3 | 52% | 41-61% | 0.0113 (2 vs 3) | |
N-stage | ||||
0 | 66% | 60-71% | 0.7206 (0 vs 1) | |
1 | 64% | 53-73% | 0.0230 (0 vs 2) | |
2 | 49% | 35-62% | 0.0790 (1 vs 2) | |
UICC stage | ||||
I | 80% | 71-87% | 0,0001 (I vs II) | |
II | 59% | 51-66% | 0.0002 (I vs III) | |
III | 59% | 50-66% | 0.9928 (II vs III) | |
Localization | ||||
right | 59% | 52-65% | 0.0512 | |
left | 68% | 61-74% |